Canopy Growth Corporation (CGC)
CGC Stock Price Chart
Explore Canopy Growth Corporation interactive price chart. Choose custom timeframes to analyze CGC price movements and trends.
CGC Company Profile
Discover essential business fundamentals and corporate details for Canopy Growth Corporation (CGC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
7 Apr 2014
Employees
1.03K
Website
https://www.canopygrowth.comCEO
Luc Mongeau
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
CGC Financial Timeline
Browse a chronological timeline of Canopy Growth Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 May 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.11.
Earnings released on 8 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.15 by +6.67%, while revenue for the quarter reached $52.75M , missing expectations by -24.21%.
Earnings released on 30 May 2025
EPS came in at -$0.94 falling short of the estimated -$0.10 by -840.00%, while revenue for the quarter reached $44.51M , missing expectations by -33.65%.
Earnings released on 7 Feb 2025
EPS came in at -$0.76 falling short of the estimated -$0.38 by -100.00%, while revenue for the quarter reached $51.92M , missing expectations by -27.89%.
Earnings released on 8 Nov 2024
EPS came in at -$0.95 falling short of the estimated -$0.38 by -150.00%, while revenue for the quarter reached $46.55M , missing expectations by -1.43%.
Earnings released on 9 Aug 2024
EPS came in at -$0.37 falling short of the estimated -$0.31 by -19.35%, while revenue for the quarter reached $48.40M , missing expectations by -4.47%.
Earnings released on 30 May 2024
EPS came in at -$0.28 surpassing the estimated -$0.33 by +15.15%, while revenue for the quarter reached $53.60M , beating expectations by +1.02%.
Earnings released on 9 Feb 2024
EPS came in at -$1.79 falling short of the estimated -$0.45 by -297.78%, while revenue for the quarter reached $59.11M , beating expectations by +11.36%.
Stock split effective on 20 Dec 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2023
EPS came in at -$1.80 falling short of the estimated -$1.20 by -50.00%, while revenue for the quarter reached $51.38M , missing expectations by -24.50%.
Earnings released on 9 Aug 2023
EPS came in at -$0.40 surpassing the estimated -$1.00 by +60.00%, while revenue for the quarter reached $82.08M , beating expectations by +20.45%.
Earnings released on 22 Jun 2023
EPS came in at -$2.30 falling short of the estimated -$1.20 by -91.67%, while revenue for the quarter reached $64.69M , missing expectations by -11.61%.
Earnings released on 9 Feb 2023
EPS came in at -$3.50 falling short of the estimated -$1.30 by -169.23%, while revenue for the quarter reached $75.43M , missing expectations by -12.55%.
Earnings released on 9 Nov 2022
EPS came in at -$2.80 falling short of the estimated -$1.80 by -55.56%, while revenue for the quarter reached $86.07M , beating expectations by +5.26%.
Earnings released on 5 Aug 2022
EPS came in at -$7.00 falling short of the estimated -$2.00 by -250.00%, while revenue for the quarter reached $85.49M , missing expectations by -2.29%.
Earnings released on 27 May 2022
EPS came in at -$4.20 falling short of the estimated -$2.40 by -75.00%, while revenue for the quarter reached $89.40M , missing expectations by -13.91%.
Earnings released on 9 Feb 2022
EPS came in at -$2.20 surpassing the estimated -$2.30 by +4.35%, while revenue for the quarter reached $110.55M , beating expectations by +2.91%.
Earnings released on 5 Nov 2021
EPS came in at -$3.90 falling short of the estimated -$1.40 by -178.57%, while revenue for the quarter reached $103.63M , missing expectations by -53.44%.
Earnings released on 6 Aug 2021
EPS came in at -$1.30 surpassing the estimated -$1.80 by +27.78%, while revenue for the quarter reached $109.89M , missing expectations by -36.86%.
Earnings released on 1 Jun 2021
EPS came in at -$6.60 falling short of the estimated -$1.80 by -266.67%, while revenue for the quarter reached $118.10M .
Earnings released on 9 Feb 2021
EPS came in at -$9.80 falling short of the estimated -$2.10 by -366.67%, while revenue for the quarter reached $119.48M , missing expectations by -82.39%.
Earnings released on 9 Nov 2020
EPS came in at $1.60 surpassing the estimated -$2.30 by +169.57%, while revenue for the quarter reached $101.60M , beating expectations by +103.24%.
CGC Stock Performance
Access detailed CGC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.